GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Huaheng Biotechnology Co Ltd (SHSE:688639) » Definitions » Asset Impairment Charge

Anhui Huaheng Biotechnology Co (SHSE:688639) Asset Impairment Charge : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anhui Huaheng Biotechnology Co Asset Impairment Charge?

Anhui Huaheng Biotechnology Co's Asset Impairment Charge for the three months ended in Mar. 2024 was ¥0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Anhui Huaheng Biotechnology Co Asset Impairment Charge Historical Data

The historical data trend for Anhui Huaheng Biotechnology Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Huaheng Biotechnology Co Asset Impairment Charge Chart

Anhui Huaheng Biotechnology Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Anhui Huaheng Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Anhui Huaheng Biotechnology Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Anhui Huaheng Biotechnology Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Anhui Huaheng Biotechnology Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Huaheng Biotechnology Co (SHSE:688639) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Huaheng Biotechnology Co Ltd (SHSE:688639) » Definitions » Asset Impairment Charge
Comparable Companies
SHSE:688166 SHSE:688177 SZSE:300294 BJSE:832982 SHSE:688578 SHSE:688336 SZSE:000403 SHSE:688278 SHSE:688739 SZSE:300009 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Shuangfeng Industrial Zone, Anhui Province, Hefei, CHN, 231131
Website
http://www.huahengbio.com
Anhui Huaheng Biotechnology Co Ltd is engaged in the research and development, production and sales of bio-based products such as amino acids and other alanine products.

Anhui Huaheng Biotechnology Co (SHSE:688639) Headlines

No Headlines